Zdrowie i gospodarka · 30/10/2017
FDA Releases Draft Guidance on Generic Drug User Fee Amendments of 2017
The FDA is releasing a draft guidance to help industry stakeholders understand and implement the Generic Drug User Fee Amendments of 2017, which were enacted in 2017 to improve the efficiency of the generic drug review process.
Source: Federal Register — Food and Drug AdministrationOpen original release →